Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYou can take Mounjaro at night before bed. The licensed schedule is a once-weekly subcutaneous injection, and the day or time of day is flexible — what counts is keeping roughly the same day each week. There is no clinical evidence that injecting in the evening causes worse outcomes than injecting in the morning. That said, some people find the timing affects how they experience early side effects, and that is the real decision worth thinking through.
Mounjaro (tirzepatide) is a prescription-only medicine licensed for weight management in adults, subject to clinical assessment by a prescriber. The notes below draw on the Mounjaro prescribing information published on the Electronic Medicines Compendium and NHS medicines guidance.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro's most common early effects are gastrointestinal: nausea, sometimes vomiting, loose stools, or that heavy, full feeling that lingers longer than you'd like. These tend to arrive within a few hours of the injection and are most noticeable in the first couple of weeks at a new dose. After that, most people's bodies adjust and the peaks soften.
If you inject on a Friday evening, the bulk of any queasiness may pass while you sleep, meaning Saturday morning arrives with the worst already behind you. That is the main practical argument for a bedtime injection. On the flip side, if you happen to be someone who finds nausea wakes them, or who already experiences disrupted sleep, an evening injection might not be the right fit.
Neither pattern is universal. People vary significantly. The SmPC does not specify a time of day, and NHS guidance on tirzepatide confirms that timing is flexible within the weekly schedule. The practical test is your own experience over the first two or three injection cycles.
One thing worth knowing: if nausea is a real concern, keeping your first injection on a day when you have no commitments the next morning gives you room to rest. Think of it like taking a new antibiotic the night before a busy week, picking the moment that gives you the most slack is sensible medicine.
The consistency rule in the prescribing information is about your day of the week, not the clock. You can shift from 8pm to 7am on the same day, or move the injection to a different day entirely as long as you leave at least four days since your last one. Narrower gaps are not recommended, your prescriber or the Patient Information Leaflet in the pack can confirm the minimum interval for your situation.
What this means practically: if you start on a Thursday evening and later decide mornings work better, you can switch. You are not locked in. The same logic applies to injection site, abdomen, thigh or upper arm, rotated each week, whatever fits your routine. Some people attach Mounjaro to an existing habit: the tablet beside the toothbrush, the pen in the fridge next to the milk, the reminder set for the same evening the bins go out.
For anyone wondering about other practical aspects of using Mounjaro (including what to do if a dose is delayed) questions about taking Mounjaro come up regularly with our prescribers, and the treatment page covers the key points. Missed-dose decisions should always follow the PIL or a conversation with your prescriber, not a forum post.
Timing your injection is a small optimisation. Whether Mounjaro is the right medicine for you at the right dose is the bigger question. Treatment is licensed for adults with a BMI of 30 or above, or 27 and above alongside at least one weight-related condition such as hypertension or high cholesterol. BMI thresholds can be lower for some ethnic backgrounds under UK guidance, the BMI requirements for Mounjaro page explains this in detail.
The prescriber who reviews your consultation looks at your full health picture, not just a number on a scale. If you are thinking about how your weight relates to eligibility, that page is a useful starting point. Dose is set by the prescriber and follows a titration schedule starting at 2.5mg, a settling-in dose whose job is to ease your system into treatment rather than drive weight loss from week one.
Side effects at higher doses can be more noticeable than at lower ones, so the timing argument for a bedtime injection tends to matter more after a dose increase than at 2.5mg. If you are preparing for your first prescription or wondering about eligibility before you start, the full eligibility overview is worth reading alongside this page.
Life does not always respect a weekly schedule. If you travel across time zones, the flexibility of a four-day minimum gap gives you room to adjust, the guidance on taking Mounjaro on a flight covers storage and timing in that context. Storage matters regardless of timing: the pen is refrigerated between 2°C and 8°C, and any out-of-fridge window should be confirmed against the Patient Information Leaflet rather than a third-party source.
Cost is a separate practical consideration for many people. Mounjaro is a private prescription in the weight-management context for most adults right now, and a realistic sense of what that involves is worth having before you start. The Mounjaro price comparison page gives an honest overview of the UK private market. If you are ready to find out whether you are eligible and want same-day clinical review by a GPhC-registered prescriber, you can start your free consultation with nume.
Reporting any unexpected effects is straightforward: the MHRA's Yellow Card scheme accepts reports from patients directly, and your prescriber should always be your first call for anything that concerns you.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.